NgenBio Reports 1.45 Billion Operating Loss in Q2... Slight Improvement Year-on-Year
[Asia Economy Reporter Lee Seon-ae] Enzen Bio announced on the 26th that it recorded an operating loss of 1,451.22 million KRW on a consolidated basis for the second quarter. This is an improvement compared to the same period last year (operating loss of 2,398.02 million KRW).
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "It's Only May, but Convenience Stores Know... Iced Americano at 24°C, Tube Ice Cream at 31°C: The Thermometer of the Summer Sales Boom"
- Mother of Three Gang-Raped on Bus in India... Outrage as Bus Driver Implicated
- "I Hated Myself as Much as I Craved It"... Even a Mother's Tears and Brilliant Dreams Were Shattered [ChwiYakGukga] ⑦
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.